Kinnate Biopharma Inc.
Key Highlights
- Kinnate Biopharma Inc. specializes in developing targeted therapies for cancer patients with specific oncogenic drivers, addressing areas where no approved drugs currently exist.
- The company's clinical programs focus on solid tumors with RAF, NRAS, and FGFR-driven alterations, demonstrating a commitment to tackling complex cancer mutations.
- Kinnate Biopharma Inc. is rapidly progressing a pipeline of small molecule drug candidates, showcasing its innovative approach to drug development.
- The company's precision medicine strategy aims to improve treatment outcomes by targeting specific genetic mutations, enhancing the effectiveness of cancer therapies.
- Kinnate Biopharma Inc.'s mission is driven by the urgency to provide new, effective cancer medicines to patients, highlighting its dedication to patient care and innovation.
About Kinnate Biopharma Inc.
Kinnate Biopharma Inc. is a clinical-stage precision oncology company based in San Diego, California, dedicated to developing targeted therapies for cancer patients. The company focuses on oncogenic drivers where no approved targeted drugs exist and aims to overcome limitations such as non-responsiveness or resistance. Kinnate has two clinical programs for solid tumors and is advancing a pipeline of small molecule drug candidates.
Founded in 2018, Kinnate Biopharma Inc. employs a team of 12 professionals committed to advancing cancer treatment. The company's mission is driven by the urgency and knowledge that patients are waiting for new, effective cancer medicines. Kinnate's approach is rooted in precision medicine, targeting specific genetic mutations to improve treatment outcomes.
Kinnate Biopharma Inc. operates as a public company, leveraging its expertise in precision oncology to address unmet medical needs in cancer therapy. The company's innovative approach and commitment to patient care make it a key player in the field of precision medicine.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
| Funding $172M |
Why Contact Kinnate Biopharma Inc.?
B2B professionals would contact Kinnate Biopharma Inc. for potential partnerships in precision oncology, vendor opportunities in targeted cancer therapies, and to explore customer prospects in the rapidly evolving field of cancer treatment. The company's innovative approach and commitment to patient care make it a valuable partner for those in the oncology sector.
Who Should Contact Kinnate Biopharma Inc. for Business?
Sales teams targeting precision oncology, recruiters seeking roles in biotechnology and pharmaceutical development, and partners offering capabilities in targeted cancer therapies should reach out to Kinnate Biopharma Inc.
Categories
- Precision Oncology
- Targeted Therapies
- Cancer Treatment
- Oncogenic Drivers
- RAF Mutations
- NRAS Mutations
- FGFR Mutations
- Clinical Programs
- Small Molecule Drugs
- Cancer Research
Frequently Asked Questions
- Who is the CEO of Kinnate Biopharma Inc.?
- The CEO and Director of Kinnate Biopharma is Nima Farzan.
- What does Kinnate Biopharma Inc. do?
- Kinnate Biopharma is a clinical-stage precision oncology company that designs and develops selective small molecule therapeutics targeting genetic mutations and fusions to treat cancer.
- How many employees does Kinnate Biopharma Inc. have?
- While specific current employee counts vary by source, the company has been reported to have a team of over 3,000 active members according to some databases, though this may include historical or network data.
- Where is Kinnate Biopharma Inc. headquartered?
- The company is headquartered in San Diego, California, at 3611 Valley Centre Dr #175.
- What industry is Kinnate Biopharma Inc. in?
- Kinnate Biopharma Inc. operates in Precision Oncology, Targeted Cancer Therapies, Clinical-Stage Biotechnology.
- When was Kinnate Biopharma Inc. founded?
- Kinnate Biopharma Inc. was founded in 2018.
- Is Kinnate Biopharma Inc. still active?
- Yes, Kinnate Biopharma Inc. was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Kinnate Biopharma Inc.?
- Research Kinnate Biopharma Inc.'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Kinnate Biopharma Inc.?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Kinnate Biopharma Inc.